Vor Biopharma Inc. Operating Lease, Payments in USD from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vor Biopharma Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to Q1 2025.
  • Vor Biopharma Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $1.69M, a 2.99% increase year-over-year.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2024 was $6.59M, a 1.01% decline from 2023.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2023 was $6.66M, a 50% decline from 2022.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2022 was $13.3M, a 420% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Vor Biopharma Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.69M +$49K +2.99% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $1.64M +$95K +6.15% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $1.54M +$817K +112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $727K +$285K +64.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $442K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Vor Biopharma Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.59M -$67K -1.01% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $6.66M -$6.65M -50% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $13.3M +$10.8M +420% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $2.56M +$1.86M +264% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $703K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.